CJC-1295 is a synthetic peptide believed to function as a growth hormone-releasing hormone (GHRH) analog. It is structurally designed to increase the half-life of endogenous growth hormone-releasing ...

Peptides have emerged as a central focus of study in various sectors due to the wide variety of biological actions that they are capable of. CJC-1295 and Ipamorelin, in particular, have garnered much ...

HOUSTON, October 06, 2025--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC ...

In this article, we present the "Mod GRF, Ipamorelin, GHRP-2 Blend," a relatively new blend of research peptides. Extensive research suggests the promising potential of this state-of-the-art ...

Peptide research has gained substantial momentum in recent years, with an increasing focus on understanding how specific peptide blends might contribute to diverse scientific implications. Peptides ...